SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-04-000515
Filing Date
2004-03-16
Accepted
2004-03-16 16:14:26
Documents
5
Period of Report
2004-01-31

Document Format Files

Seq Description Document Type Size
1 peregrine_10q-013104.txt 10-Q 120231
3 peregrine_10qex10-92.txt EX-10.92 37464
4 peregrine_10qex31-1.txt EX-31.1 3257
5 peregrine_10qex31-2.txt EX-31.2 3261
6 peregrine_10qex32.txt EX-32 1516
  Complete submission text file 0001019687-04-000515.txt   167785
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-17085 | Film No.: 04672932
SIC: 2835 In Vitro & In Vivo Diagnostic Substances